Coronally Advanced Flap in Combination With Acellular Dermal Matrix and Enamel Matrix Derivatives for Root Coverage

This study has been completed.
Sponsor:
Information provided by:
Tabriz University
ClinicalTrials.gov Identifier:
NCT00720707
First received: July 22, 2008
Last updated: NA
Last verified: July 2008
History: No changes posted

July 22, 2008
July 22, 2008
April 2006
February 2007   (final data collection date for primary outcome measure)
the percentage of root coverage [ Time Frame: at baseline, 2 and 6 months after treatment. ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
clinical attachment level, width of keratinized gingiva ant the position of mucco-gingival junction following root coverage procedures [ Time Frame: 6 months after treatment ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Coronally Advanced Flap in Combination With Acellular Dermal Matrix and Enamel Matrix Derivatives for Root Coverage
Coronally Advanced Flap in Combination With Acellular Dermal Matrix With or Without Enamel Matrix Derivatives for Root Coverage

The aim of this study is to compare the clinical outcomes of root coverage procedures, using coronally advanced flap in combination with acellular dermal matrix with or without enamel matrix derivatives .

coverage of gingival recession defects has been considered as a matter of interest for dental practitioners.subjects with a paired gingival recession defect will be selected from the patients who sought dental treatment at our department.Random allocation of the treatment sites to test (CAF+ EMD+ADM) and control (CAF + ADM) groups will be performed by a person who is external to the study and using a computerized selection of random numbers for allocation of the study groups.The parameters of the study are as following items: probing depth( PD), clinical attachment level (CAL), width of keratinized tissue (WKT), recession depth from cemento- enamel junction (RD), recession width (RW), distance between mucogingival junction and the stent (MGJ), Plaque (PI) and gingival (GI) indices and root coverage percentage (RC) and the patients will be followed up for 6 months.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Gingival Recession
  • Procedure: CAF+ADM+EMD
    using coronally advanced flap (CAF) in combination with acellular dermal matrix (ADM) with enamel matrix derivatives (EMD).
    Other Names:
    • Alloderm®
    • Emdogain®
  • Procedure: CAF+ADM
    using coronally advanced flap (CAF) in combination with acellular dermal matrix (ADM) without enamel matrix derivatives (EMD) for root coverage procedures.
    Other Names:
    • Alloderm®
    • Emdogain®
  • Experimental: (CAF+ADM+EMD)
    using coronally advanced flap (CAF) in combination with acellular dermal matrix (ADM) with enamel matrix derivatives (EMD).
    Intervention: Procedure: CAF+ADM+EMD
  • Active Comparator: (CAF + ADM)
    root coverage procedure by using a coronally advanced flap (CAF) in combination with acellular dermal matrix (ADM)
    Intervention: Procedure: CAF+ADM
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18
March 2007
February 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Having no systemic disease affecting the periodontium,
  • No contraindication for elective surgery,
  • Adequate oral hygiene ,
  • No previous surgical attempts for root coverage at the studying sites,
  • Vital teeth and signing a witness letter.

Exclusion Criteria:

  • Smoking, presence of a restorations on tooth surface for test and control teeth,
  • Pregnancy,
  • Being under treatment with steroids,
  • Peri-apical infection,
  • Indication for antibiotic prophylaxis prior to dental treatments
Both
20 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Iran, Islamic Republic of
 
NCT00720707
841
Yes
Dr. Reza Pourabbas, Tabriz University of Medical Sciences
Tabriz University
Not Provided
Principal Investigator: Reza Pourabbas, DDS Tabriz University (Medical Sciences)
Tabriz University
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP